A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Mise à jour : Il y a 4 ans
Référence : NCT01751152

Femme et Homme

Extrait

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to assess clinical efficacy and safety of NNC0114-0006 in subjects with active Crohn's disease.


Critère d'inclusion

  • Inflammation ,Crohn’s Disease


Liens